Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])

American Journal of Cardiology

Volumn 88, Issue 2, 2001, Pages 107-111

  Spencer, Frederick A ^a,c   Goldberg, Robert J ^a   Frederick, Paul D ^b   Malmgren, Judith ^b   Becker, Richard C ^a   Gore, Joel M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; FAMILY HISTORY; FIBRINOLYTIC THERAPY; GEOGRAPHY; GROUPS BY AGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REVASCULARIZATION; SOCIAL STATUS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

AGE FACTORS; AGED; CORONARY ANGIOGRAPHY; CROSS-SECTIONAL STUDIES; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; REGRESSION ANALYSIS; THROMBOLYTIC THERAPY; UNITED STATES;

EID: 0035879694     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01602-2     Document Type: Article

References (13)

1. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
2. SWIFT trial of delayed elective intervention vs. conservative treatment after thrombolysis with anistreplase in acute myocardial infarction
3. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial
4. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction
5. Treatment of myocardial infarction in the United States (1990 to 1993); observations from the National Registry of Myocardial Infarction
6. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) phase II trial
7. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients
8. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study
9. A comparison of U. S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: Efficiency, yield and long-term implications
10. Coronary angiography after thrombolytic therapy for acute myocardial infarction
11. Regional variation across the United States in the management of acute myocardial infarction
12. Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States
13. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction